comparemela.com

Latest Breaking News On - Zevra therapeutics inc - Page 1 : comparemela.com

KP1077 Demonstrates Safety in Idiopathic Hypersomnia Patients

Zevra Therapeutics, Inc (NASDAQ:ZVRA) Receives $19 50 Consensus Price Target from Analysts

Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) has received a consensus rating of “Buy” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have updated their coverage on the stock in the […]

Roth Capital Equities Analysts Increase Earnings Estimates for Zevra Therapeutics, Inc (NASDAQ:ZVRA)

Roth Capital Equities Analysts Increase Earnings Estimates for Zevra Therapeutics, Inc (NASDAQ:ZVRA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

FY2027 EPS Estimates for Zevra Therapeutics, Inc Increased by Analyst (NASDAQ:ZVRA)

FY2027 EPS Estimates for Zevra Therapeutics, Inc Increased by Analyst (NASDAQ:ZVRA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.